title: Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion.
abstract: Cell invasion through extracellular matrix (ECM) is a hallmark of the metastatic cascade. Cancer cells require adhesion to surrounding tissues for efficient migration to occur, which is mediated through the integrin family of receptors. Alterations in expression levels of β1 and β3 integrins have previously been reported in a number of human cancers. However, whether there are specific roles for these ubiquitous receptors in mediating cell invasion remains unclear. Here we demonstrate that loss of β1 but not β3 integrins leads to increased spread cell area and focal adhesion number in cells on 2D immobilized fibronectin. Increased adhesion numbers in β1 knockdown cells correlated with decreased cell migration on 2D surfaces. Conversely, cells depleted of β1 integrins showed increased migration speed on 3D cell-derived matrix as well as in 3D organotypic cultures and inverted invasion assays. This increased invasive potential was also seen in cells lacking β3 integrin but only in 3D cultures containing fibroblasts. Mechanistically, in situ analysis using FRET biosensors revealed that enhanced invasion in cells lacking β1 integrins was directly coupled with reduced activation of focal adhesion kinase (FAK) and the small GTPase RhoA resulting in formation of enhanced dynamic protrusions and increased invasion. These reductions in FAK-RhoA signal activation were not detected in β3 knockdown cells under the same conditions. This data demonstrates a specific role for β1 integrins in the modulation of a FAK-RhoA-actomyosin signaling axis to regulate cell invasion through complex ECM environments.
authors.affiliation: Randall Division of Cell and Molecular Biophysics, King's College London, London, United Kingdom.
authors.forename: Patricia
authors.initials: P
authors.lastname: Costa
authors.forename: Tim M E
authors.initials: TM
authors.lastname: Scales
authors.forename: Johanna
authors.initials: J
authors.lastname: Ivaska
authors.forename: Maddy
authors.initials: M
authors.lastname: Parsons
mesh_terms: D000199:Actins / Q000378:metabolism; D000205:Actomyosin / Q000378:metabolism; D002277:Carcinoma / Q000378:metabolism; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism*; D002465:Cell Movement; D005347:Fibroblasts / Q000378:metabolism; D005353:Fibronectins / Q000737:chemistry; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D021621:Imaging, Three-Dimensional; D019012:Integrin beta1 / Q000378:metabolism*; D039661:Integrin beta3 / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D015398:Signal Transduction; D020742:rhoA GTP-Binding Protein / Q000378:metabolism*
chemical_list: D000199:Actins; D005353:Fibronectins; D019012:Integrin beta1; D039661:Integrin beta3; C066737:RHOA protein, human; D000205:Actomyosin; D051416:Focal Adhesion Protein-Tyrosine Kinases; D020742:rhoA GTP-Binding Protein
references.citation: EMBO J. 2011 May 4;30(9):1705-18
references.pmid: 21427700
references.citation: J Cell Sci. 2009 Apr 15;122(Pt 8):1059-69
references.pmid: 19339545
references.citation: Nat Med. 2002 Jan;8(1):27-34
references.pmid: 11786903
references.citation: Nat Cell Biol. 2007 Dec;9(12):1392-400
references.pmid: 18037882
references.citation: Biochem Biophys Res Commun. 2011 Aug 19;412(1):98-103
references.pmid: 21802412
references.citation: J Biol Chem. 2004 Jul 9;279(28):28889-95
references.pmid: 15143061
references.citation: J Cell Biol. 2005 May 9;169(3):515-26
references.pmid: 15866889
references.citation: J Cell Biol. 2003 Jul 21;162(2):223-32
references.pmid: 12860967
references.citation: Nature. 2008 Dec 18;456(7224):957-61
references.pmid: 19078960
references.citation: Cell. 2011 Jun 24;145(7):1012-22
references.pmid: 21703446
references.citation: J Cell Biol. 2008 Mar 24;180(6):1245-60
references.pmid: 18362183
references.citation: Oncogene. 2013 Aug 22;32(34):3965-79
references.pmid: 22986527
references.citation: Mol Biol Cell. 2003 Mar;14(3):1074-84
references.pmid: 12631724
references.citation: Cell. 2009 Nov 25;139(5):891-906
references.pmid: 19931152
references.citation: Cancer Cell. 2004 Aug;6(2):159-70
references.pmid: 15324699
references.citation: Genes Dev. 1995 Aug 1;9(15):1896-908
references.pmid: 7544313
references.citation: J Biol Chem. 2003 Jul 4;278(27):24865-73
references.pmid: 12702722
references.citation: Mol Imaging. 2008 Sep-Oct;7(5):199-213
references.pmid: 19123990
references.citation: Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49
references.pmid: 19169797
references.citation: J Pathol. 2005 Mar;205(4):468-75
references.pmid: 15685705
references.citation: Clin Exp Metastasis. 2009;26(4):289-98
references.pmid: 18600304
references.citation: J Cell Biol. 1998 Sep 7;142(5):1357-69
references.pmid: 9732295
references.citation: Cell. 2011 Jul 8;146(1):148-63
references.pmid: 21729786
references.citation: J Cell Sci. 2008 Feb 1;121(Pt 3):265-71
references.pmid: 18216331
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: J Biol Chem. 2007 May 18;282(20):14845-52
references.pmid: 17395594
references.citation: Development. 2008 May;135(10):1771-80
references.pmid: 18403410
references.citation: J Clin Invest. 1999 Jan;103(2):229-38
references.pmid: 9916135
references.citation: Blood. 2004 May 1;103(9):3388-95
references.pmid: 14726375
references.citation: Mol Cancer Ther. 2011 Nov;10(11):2135-45
references.pmid: 21903606
references.citation: Int J Biochem Cell Biol. 2009 Jul;41(7):1511-7
references.pmid: 19166965
references.citation: Cell Cycle. 2009 Jul 15;8(14):2219-25
references.pmid: 19617714
references.citation: Cancer Metastasis Rev. 2009 Jun;28(1-2):65-76
references.pmid: 19160018
references.citation: Science. 2004 Feb 6;303(5659):848-51
references.pmid: 14764882
references.citation: J Cell Biol. 2008 Oct 6;183(1):143-55
references.pmid: 18838556
references.citation: Cancer Res. 2007 Jun 1;67(11):5275-84
references.pmid: 17545607
references.citation: Oncogene. 2011 Mar 24;30(12):1436-48
references.pmid: 21057535
references.citation: Mol Biol Cell. 2006 Nov;17(11):4827-36
references.pmid: 16971514
references.citation: J Cell Biol. 2008 Jan 14;180(1):187-203
references.pmid: 18195107
references.citation: Exp Cell Res. 1998 May 1;240(2):368-76
references.pmid: 9597010
references.citation: J Cell Biol. 2010 Apr 19;189(2):369-83
references.pmid: 20404115
references.citation: Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26
references.pmid: 15459662
references.citation: Nat Rev Cancer. 2009 Feb;9(2):108-22
references.pmid: 19165226
references.citation: J Cell Biol. 2009 Apr 20;185(2):357-70
references.pmid: 19364917
references.citation: J Cell Sci. 2010 May 1;123(Pt 9):1385-8
references.pmid: 20410370
references.citation: Cancer Res. 2007 Dec 15;67(24):11621-9
references.pmid: 18089791
references.citation: Hum Gene Ther. 2002 May 1;13(7):803-13
references.pmid: 11975847
references.citation: Oncogene. 1999 Jul 1;18(26):3852-61
references.pmid: 10445848
references.citation: Nat Methods. 2008 Jul;5(7):605-7
references.pmid: 18536722
references.citation: Cancer Metastasis Rev. 2010 Mar;29(1):223-37
references.pmid: 20112053
references.citation: Methods Mol Biol. 2011;769:111-36
references.pmid: 21748673
references.citation: J Cell Sci. 2009 Mar 1;122(Pt 5):656-66
references.pmid: 19208768
references.citation: Cancer Res. 2011 Jan 15;71(2):360-70
references.pmid: 21224360